Recruiting Lupus Studies in Ann Arbor
Down Syndrome Obstructive Sleep Apnea
The purpose of this study is to assess whether oxygen supplementation during sleep improves working memory and other clinical and patient-reported outcomes among children who have Down Syndrome (DS) w...
A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
In this study, researchers will learn more about the use of felzartamab in people with active lupus nephritis, also known as LN. In people with LN, antibodies build up in the glomeruli of the kidneys....
About Lupus Clinical Trials in Ann Arbor
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.
There are currently 2 lupus clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 250 participants. Research is being sponsored by Brigham and Women's Hospital, HI-Bio, A Biogen Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Clinical Trials in Ann Arbor — FAQ
Are there lupus clinical trials in Ann Arbor?
Yes, there are 2 lupus clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ann Arbor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.
Are clinical trials in Ann Arbor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.
What lupus treatments are being tested?
The 2 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.
Data updated March 2, 2026 from ClinicalTrials.gov